Suppr超能文献

人体肝移植后活检指导下的免疫抑制治疗。

Biopsy-directed immunosuppression following hepatic transplantation in man.

作者信息

Williams J W, Peters T G, Vera S R, Britt L G, van Voorst S J, Haggitt R C

出版信息

Transplantation. 1985 Jun;39(6):589-96. doi: 10.1097/00007890-198506000-00003.

Abstract

Patients undergoing orthotopic hepatic transplantation were studied with routinely available liver function studies and serial hepatic biopsies. Rejection was diagnosed only if confirmed histologically. Cyclosporine and a rapidly decreasing dose of corticosteroids were used for immunosuppression. Hepatic dysfunction suggesting rejection was seen in 22 instances, but acute rejection was diagnosed histologically in only 6 patients. The liver function studies used in these patients did not accurately distinguish rejection from other causes of hepatic dysfunction. We conclude that liver biopsy as performed in these patients is an accurate and safe means of assessing the adequacy of immunosuppression and minimizing the use of high dose corticosteroids.

摘要

对接受原位肝移植的患者进行了常规肝功能检查和系列肝脏活检。仅在组织学确诊时才诊断为排斥反应。使用环孢素和快速递减剂量的皮质类固醇进行免疫抑制。22例出现提示排斥反应的肝功能障碍,但仅6例患者经组织学诊断为急性排斥反应。这些患者所使用的肝功能检查未能准确区分排斥反应与肝功能障碍的其他原因。我们得出结论,对这些患者进行的肝脏活检是评估免疫抑制是否充分以及尽量减少高剂量皮质类固醇使用的准确且安全的方法。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验